Abstract
Pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare subtype of non-small cell lung cancer, endemic in southeast Asia. LELC has histologic resemblance to undifferentiated nasopharyngeal carcinoma, which is highly sensitive to gemcitabine-platinum chemotherapy. Evidence to support this treatment in LELC is however limited. This study aims to evaluate the efficacy of gemcitabine-cisplatin (GP) or gemcitabine-carboplatin (GC) in relapsed or metastatic pulmonary LELC.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call